NVDA
NVIDIA Corporation
NVDA has the edge over PD overall, supported by stronger valuation and stronger modeled upside.
PD
PagerDuty, Inc.
PD's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
PD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
PD's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over PD in the historical PE scenario, which offers more potential upside but is not a forecast.
PD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.9x | $7.84 | -50% |
| Fair | 5.1x | $10.33 | -34% |
| Expensive | 7.7x | $15.69 | -0.2% |
| Current | 7.7x | $15.72 | — |
| Forward | 11x | $15.72 | — |
Historical ranges are pointers, not guarantees.
PD's PE is 7.7x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
PD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect PD's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
PD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.43 | -29% |
| Q3 2026 | $2.03 | +$2.19 |
| Q2 2026 | $2.07 | +$2.47 |
| Q1 2026 | $1.87 | +$2.46 |
| Q4 2025 | $1.60 | +$2.41 |
| Q3 2025 | -$0.16 | +$0.74 |
| Q2 2025 | -$0.40 | +$0.62 |
| Q1 2025 | -$0.59 | +$0.30 |
| Q4 2024 | -$0.81 | +$0.01 |
PD has returned to profit: it earned $2.03 per share over the past year, after losing money the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over PD on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over PD on profitability, with a higher operating margin.
PD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $124.4M | +0.8% |
| Q2 2026 | $121M | +1% |
| Q1 2026 | $124.8M | +2.7% |
| Q4 2025 | $124.5M | +4.7% |
| Q3 2025 | $123.4M | +6.4% |
| Q2 2025 | $119.8M | +7.8% |
| Q1 2025 | $121.4M | +9.3% |
| Q4 2024 | $118.9M | +9.4% |
PD's revenue has grown year over year every quarter since late 2020: $124M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +5.3 points |
| Q2 2026 | 7.6% | +16 points |
| Q1 2026 | 3.6% | +13 points |
| Q4 2025 | 6.5% | +15 points |
| Q3 2025 | 2.9% | +17 points |
| Q2 2025 | -8.6% | +11 points |
| Q1 2025 | -9.7% | +20 points |
| Q4 2024 | -8.7% | +11 points |
PD's operating margin was 8.2% last quarter, up 5.3 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over PD on cash flow, with more consistent year-over-year improvement.
PD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $34.7M | +4.9% |
| Q2 2026 | $43.3M | +43% |
| Q1 2026 | $24.5M | -19% |
| Q4 2025 | $24.1M | +12% |
| Q3 2025 | $33.1M | -5.8% |
| Q2 2025 | $30.2M | +7.2% |
| Q1 2025 | $30.3M | +43% |
| Q4 2024 | $21.5M | +29% |
PD generated $127M in free cash flow over the past year, up 10% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
PD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.3x | Net Cash |
| Q2 2026 | -5.6x | Net Cash |
| Q1 2026 | 9.7x | High |
| Q4 2025 | -68.2x | Net Cash |
PD has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
PD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.7 | Neutral |
| Stochastic | 73.7 | Neutral |
PD's weekly RSI is 65 (neutral) and its Stochastic is 74 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
PD PE vs Technology Sector
| Metric | PD | Sector median | Relative |
|---|---|---|---|
| PE | 7.7x | 28x | 72% below |
| PE % | 84 | 35 | 49 pts above |
PD has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
PD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.0 | 1.6% below |
| 20 week MA | $13.5 | 17% above |
| 50 week MA | $10.7 | 47% above |
| 100 week MA | $13.6 | 16% above |
| 200 week MA | $18.4 | 15% below |
PD has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
PD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.3 | $46.1 | +98% |
| 2021 | $46.1 | $36.2 | -22% |
| 2022 | $36.2 | $26.6 | -27% |
| 2023 | $26.6 | $23.2 | -13% |
| 2024 | $23.2 | $17.8 | -23% |
| 2025 | $17.8 | $13.2 | -26% |
| 2026 YTD | $13.2 | $15.7 | +19% |
PD has the edge over NVDA on returns for 2026, with the stronger performance.